Clinical trial
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women…
NCT00377234 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00377234 |
|---|---|
| Title | A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis. |
| Official title | Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Post Menopausal Osteoporosis |
| Intervention type | Drug |
| Interventions | Risedronate, ibandronate [Bonviva/Boniva] |
| Enrollment | 356 |
| Start date | May 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Sep 18, 2006 |
| Last update posted | Aug 1, 2016 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: